Clinical Trials Directory

Trials / Completed

CompletedNCT05717114

Dexmetomedine as an Adjuvant to Bupivacaine in Ultrasound Guided PECS Block

Efficacy of Different Doses of Dexmetomedine as an Adjuvant to Bupivacaine in Ultrasound Guided PECS Block in Patients Undergoing Modified Radical Mastectomy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
96 (actual)
Sponsor
Menoufia University · Academic / Other
Sex
Female
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

Regional anesthesia is an essential component of anesthesia and analgesia. It has many advantages, it decreases pain post operatively, improves patient outcome and allow early recovery and ambulation Post-operative pain following breast surgery results from injured muscles and nerves, management of acute post operative pain is a consistent factor for better outcome and patient satisfaction

Detailed description

All patients will be monitored by standard intraoperative monitoring that includes continuous electrocardiography (ECG), capnography, pulse oximetry, and non invasive blood pressure. Induction of general anesthesia will be done by propofol 1.5-2 mg/kg and fentanyl 3µg/kg. Tracheal intubation will be facilitated by administration of rocuronium 0.8 mg/kg. Anesthesia will be maintained with isoflurane 1MAC (Pecs block):the block will be performed with the patients in the supine position.The infraclavicular and axillary regions will be cleaned with antiseptic solution. the in plane technique will be used from proximal and medial to distal and lateral in an oblique manner at dermatome level T2 and T3.The puncture site was infiltrated with 2%lidocaine and once the structures is identified with Ultrasound

Conditions

Interventions

TypeNameDescription
PROCEDUREPecs block(Pecs block):the block will be performed with the patients in the supine position.The infraclavicular and axillary regions will be cleaned with antiseptic solution. the inplane technique will be used from proximal and medial to distal and lateral in an oblique manner at dermatome level T2and T3.The puncture site was infiltrated with 2%lidocaine and once the structures is identified with ultrasound.

Timeline

Start date
2023-02-05
Primary completion
2023-12-25
Completion
2024-01-01
First posted
2023-02-08
Last updated
2024-01-31

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05717114. Inclusion in this directory is not an endorsement.